Clinical Features and Disease Course of Cancer Patients Infected with Sars-Cov-2 During Anticancer Treatments

1 Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. Search in Google Scholar

2 World Health Organization. WHO Director General’s opening remarks at the media briefing on COVID-19. 2020. Available at: www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19. Accessed Jun 20, 2020. Search in Google Scholar

3 El-Shakankery KH, Kefas J, Crusz SM. Caring for our cancer patients in the wake of COVID-19. Br J Cancer. 2020;123(1):3-4. Search in Google Scholar

4 Lewis MA. Between Scylla and Charybdis - Oncologic Decision Making in the Time of Covid-19. N Engl J Med. 2020;382(24):2285-2287. Search in Google Scholar

5 European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. Available at: www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic. Accessed August 2, 2020. Search in Google Scholar

6 National Institutes of Helth. COVID-19 Treatment Guidelines. Management of Persons with COVID-19. Available at: www.covid19treatmentguidelines.nih.gov/overview/management-of-covid-19. Accessed August 2, 2020. Search in Google Scholar

7 Von Lilienfeld-Toal M, Vehreschild JJ, Cornely O, et al. Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases. Leukemia. 2020;34(6):1487-1494. Search in Google Scholar

8 Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA. 2020;10.1001/jama.2020.2648. Search in Google Scholar

9 Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. Search in Google Scholar

10 Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919-1926. Search in Google Scholar

11 World Health Organization. Clinical management of COVID-19. Interim guidance, 27 May 2020. Available at: www.who.int/publications/i/item/clinical-management-of-covid-19 . Accessed August 30, 2020. Search in Google Scholar

12 European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 - first update. Available at: www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidance-discharge-and-ending-isolation-first%20update.pdf. Accessed August 28, 2020. Search in Google Scholar

13 Wang F, Nie J, Wang H, et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020;221(11):1762-1769. Search in Google Scholar

14 Czawlytko C, Hossain R, White CS. COVID-19 Diagnostic Imaging Recommendations. Appl Radiol. 2020; 49(3):10-15 Search in Google Scholar

15 World Health Organization. Use of chest imaging in COVID-19. A rapid advice guide, 11. June 2020. Available at: www.who.int/publications/i/item/use-of-chest-imaging-in-covid-19. Accessed August 28, 2020. Search in Google Scholar

16 Cozzi D, Albanesi M, Cavigli E, et al. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome. Radiol Med. 2020;125(8):730-737. Search in Google Scholar

17 Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904-913. Search in Google Scholar

18 Esposito S, Noviello S, Pagliano P. Update on treatment of COVID-19: ongoing studies between promising and disappointing results. Infez Med. 2020;28(2):198-211. Search in Google Scholar

19 Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study [published online ahead of print, 2020 Aug 24]. Lancet Oncol. 2020;S1470-2045(20)30442-3. Search in Google Scholar

20 Vijayvargiya P, Esquer Garrigos Z, Castillo Almeida NE, Gurram PR, Stevens RW, Razonable RR. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof). Mayo Clin Proc. 2020;95(7):1454-1466. Search in Google Scholar

21 Xu W, Piper-Vallillo AJ, Bindal P, et al. Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19. Preprint. medRxiv. 2020;2020.07.23.2016 1000. Search in Google Scholar